Table 2 Operation method, pathological findings, receptor status, treatment and outcome
From: Surgical treatment of intracystic carcinoma of the breast
No | Operative method | P-stage | Grade | Extramural invasion | Vascular invasion | Receptor status | Medical treatment |
|---|---|---|---|---|---|---|---|
1 | Bt+Ax | 0 | I | - | ly(-) v(-) | ER(1+) PgR(2+) HER2(3+) | Endocrine therapy (TAM) |
2 | Bp+Ax | I | I | +(IDC) | ly(-) v(-) | ER(-) PgR(-) HER2(-) | - |
3 | Bp | 0 | I | - | ly(-) v(-) | ER(3+) PgR(3+) HER2(2+) | Endocrine therapy (AI) |
4 | Bt+SN | I | II | +(IDC) | ly(-) v(-) | ER(3+) PgR(-) HER2(-) | Endocrine therapy (AI) |
5 | Bt+SN | I | I | +(DCIS) | ly(-) v(-) | ER(3+) PgR(3+) HER2(1+) | Endocrine therapy (AI) |
6 | Bp+SN | I | I | +(IDC) | ly(-) v(+) | ER(3+) PgR(3+) HER2(-) | Endocrine therapy (AI) |